Hoaxon-NT Tablet contains a combination of Pregabalin 75mg and Nortriptyline 10mg, formulated for the management of neuropathic pain and certain mood disorders. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, modulates calcium channels in the central nervous system, reducing neurotransmitter release and thereby alleviating neuropathic pain symptoms such as burning, shooting, or stabbing sensations. Nortriptyline, a tricyclic antidepressant, inhibits the reuptake of norepinephrine and serotonin, enhancing mood and providing additional analgesic effects through modulation of pain pathways. This combination is particularly effective in patients with chronic neuropathic pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia, where both pain control and mood stabilization are necessary. Hoaxon-NT should be administered under medical supervision, with dosage adjustments based on therapeutic response and tolerability. Common adverse effects may include dizziness, dry mouth, somnolence, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac arrhythmias, glaucoma, or renal impairment. Pregnant or lactating women should use this medication only if clearly needed. Hoaxon-NT Tablet offers a dual mechanism approach, improving patient outcomes by addressing both neuropathic pain and associated depressive symptoms.